Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6063802 | SANDOZ | Ondansetron freeze-dried dosage form compositions for oral administration |
Nov, 2015
(8 years ago) | |
US5955488 | SANDOZ | Freeze-dried compositions |
Nov, 2015
(8 years ago) | |
US5955488 (Pediatric) | SANDOZ | Freeze-dried compositions |
May, 2016
(7 years ago) | |
US6063802 (Pediatric) | SANDOZ | Ondansetron freeze-dried dosage form compositions for oral administration |
May, 2016
(7 years ago) |
Market Authorisation Date: 27 January, 1999
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8580830 | AQUESTIVE | Non-mucoadhesive film dosage forms |
Nov, 2029
(5 years from now) | |
US9095577 | AQUESTIVE | Stabilized amine-containing actives in oral film compositions |
Jul, 2030
(6 years from now) |
Market Authorisation Date: 02 July, 2010
Treatment: NA
Dosage: FILM;ORAL